Last reviewed · How we verify
NCT04207632
Quantifying Muscle Tone in Patients With Brain Injury - a Feasibility Study
trial testing Botulinum toxin type A injection in Treatment Outcome in 5 participants. Status unknown.
15 January 2021
Quick facts
| Lead sponsor | Rigshospitalet, Denmark |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 5 |
| Start date | 1 April 2020 |
| Primary completion | 15 January 2021 |
| Estimated completion | 1 April 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Botulinum toxin type A injection — full drug profile →
Conditions studied
- Treatment Outcome — all drugs for Treatment Outcome →
- Muscle Dystonia — all drugs for Muscle Dystonia →
- Spasticity, Muscle — all drugs for Spasticity, Muscle →
- Muscle Tightness — all drugs for Muscle Tightness →
Sponsor
Rigshospitalet, Denmark
Who can join
Adults 5 to 99, any sex, with Treatment Outcome or Muscle Dystonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project will determine the feasibility and validity of measuring elbow muscle flexor stiffness in a population of patients with sub-acute severe acquired brain injury using two measurement methods, the portable spasticity assessment device (PSAD) (Movotec, Charlottenlund, Denmark) and an ultrasound measurement called shear wave sonoelastography (SWE).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04207632
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Botulinum toxin type A injection
Trials testing the same drug.
- NCT06886750 — The Effects of Waning of Botulinum Toxin in the Treatment of Cervical Dystonia · Phase 4 · not yet recruiting
- NCT06094309 — Effectiveness of Botulinum Toxin in Freezing of Gate in Parkinson's Disease Walking in Parkinson's Disease. · NA · unknown
- NCT05651256 — Efficacy of Botulinum Toxin in Temporomandibular Disorders · Phase 2, PHASE3 · completed
- NCT04171258 — Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia · Phase 1 · completed
- NCT04186442 — Evaluate the Safety and Efficacy of Botulax® Versus Botox® in Patient With Overactive Bladder · Phase 1 · completed
Other recruiting trials for Treatment Outcome
Currently open trials in the same condition.
- NCT07018167 — Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital · active not recruiting
- NCT07054892 — Assessment of the Quality of Life of Patients Visiting the Emergency Department of the Saint-Brieuc Hospital Following a · recruiting
- NCT07034560 — Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma · Phase 4 · active not recruiting
- NCT06864221 — Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma · recruiting
- NCT06966141 — A Real World Study of Sacituzumab Govitecan · recruiting
Other Rigshospitalet, Denmark trials
Trials by the same sponsor.
- NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
- NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
- NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
- NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
- NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04207632 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
- Last refreshed: 26 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04207632.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing